Slow infusion of vincristine in the treatment of idiopathic thrombocytopenic purpura
- 1 February 1986
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 21 (2) , 135-138
- https://doi.org/10.1002/ajh.2830210203
Abstract
Ten patients with idiopathic thrombocytopenic purpura (ITP) were treated wtih vincristine (VCR), given as a slow infusion over a 4‐hr period, at weekly intervals for 4 weeks. The VCR therapy achieved a sustained recovery of platelet count in five patients with ITP of 2 weeks to 5 months duration; a transient recovery was observed in four patients with ITP of 6 months to 5 years duration. Therapy had no effect at all in one patient who had ITP of 10 years duration. Vincristine therapy appears to be therapeutically more beneficial when given as a slow infusion and can achieve sustained recovery of platelet count in patients with ITP of less than six months duration.Keywords
This publication has 4 references indexed in Scilit:
- Slow Infusion of Vinca Alkaloids in the Treatment of Idiopathic Thrombocytopenic PurpuraAnnals of Internal Medicine, 1984
- Long‐Term Follow‐Up Study of 168 Patients with Immune Thrombocytopenia. Implications for TherapyScandinavian Journal of Haematology, 1984
- Autoimmune thrombocytopenic purpuraBlood, 1980
- Vincristine Therapy of Idiopathic and Secondary ThrombocytopeniasNew England Journal of Medicine, 1974